Page last updated: 2024-09-03

n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and trelstar

n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine has been researched along with trelstar in 1 studies

Compound Research Comparison

Studies
(n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine)
Trials
(n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine)
Recent Studies (post-2010)
(n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine)
Studies
(trelstar)
Trials
(trelstar)
Recent Studies (post-2010) (trelstar)
250121,998483490

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blazsek, I; Bourut, C; Chenu, E; Lemaigre, G; Maral, R; Mathé, G; Mauvernay, Y; Schally, AV1

Other Studies

1 other study(ies) available for n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and trelstar

ArticleYear
Experimental protection by a luteinizing hormone-releasing hormone agonist of a bone marrow nitrosourea aplasia. Preliminary observations.
    Cancer letters, 1984, Volume: 25, Issue:2

    Topics: Animals; Body Weight; Bone Marrow; Bone Marrow Diseases; Double-Blind Method; Gonadotropin-Releasing Hormone; Hematopoietic Stem Cells; Luteolytic Agents; Male; Mice; Nitrosourea Compounds; Triptorelin Pamoate

1984